Timothy J. Miller
Vorstandsvorsitzender bei Forge Biologics Holdings LLC
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Christine Silverstein | F | 41 | 8 Jahre | |
| Brendan OMalley | M | 55 | 5 Jahre | |
| Christopher Garabedian | M | 57 |
Forge Biologics Holdings LLC
 Forge Biologics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Forge Biologics Holdings LLC engages in the provision of biotechnology services. The company is headquartered in Grove City, OH. | - |
| Molly J. McCartin | F | - |
Forge Biologics Holdings LLC
Forge Biologics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Forge Biologics Holdings LLC engages in the provision of biotechnology services. The company is headquartered in Grove City, OH. | - |
| Brian Kevany | M | - | 6 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jeffrey Davis | M | 61 | 12 Jahre | |
| Stephen B. Thompson | M | 70 | 3 Jahre | |
| Joao Siffert | M | 60 | 2 Jahre | |
| Edward Carr | M | 55 | - | |
| Mark J. Ahn | M | 61 | 11 Jahre | |
| Edward Sturchio | M | - | 1 Jahre | |
| Neena Patil | F | 49 | 1 Jahre | |
| James Bircher | M | 56 | - | |
| Richard van Dyune | M | 70 | 2 Jahre | |
| Evan A. Facher | M | - |
SironRX Therapeutics, Inc.
 SironRX Therapeutics, Inc. Hospital/Nursing ManagementHealth Services SironRX Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. Its technology is stromal cell-derived factor-1 is a naturally occurring chemokine that is rapidly over-expressed in response to tissue injury, particularly during ischemia. The firm is developing novel therapies that promote wound repair and prevent scarring of dermal wounds. The company was founded by Marc S. Penn and Rahul Aras in 2010 and is headquartered in Cleveland, OH. | - |
| Stefano Buono | M | 57 | 2 Jahre | |
| F. Carsten Thiel | M | 61 | - | |
| Marc Penn | M | - |
SironRX Therapeutics, Inc.
SironRX Therapeutics, Inc. Hospital/Nursing ManagementHealth Services SironRX Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. Its technology is stromal cell-derived factor-1 is a naturally occurring chemokine that is rapidly over-expressed in response to tissue injury, particularly during ischemia. The firm is developing novel therapies that promote wound repair and prevent scarring of dermal wounds. The company was founded by Marc S. Penn and Rahul Aras in 2010 and is headquartered in Cleveland, OH. | - |
| Juan Ruiz | M | - | - | |
| Jodie Gillon | F | - | 2 Jahre | |
| Victor Paulus | M | - | - | |
| Harrison Wehner | M | 59 | 3 Jahre | |
| Rahul A. Aras | M | - |
SironRX Therapeutics, Inc.
SironRX Therapeutics, Inc. Hospital/Nursing ManagementHealth Services SironRX Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. Its technology is stromal cell-derived factor-1 is a naturally occurring chemokine that is rapidly over-expressed in response to tissue injury, particularly during ischemia. The firm is developing novel therapies that promote wound repair and prevent scarring of dermal wounds. The company was founded by Marc S. Penn and Rahul Aras in 2010 and is headquartered in Cleveland, OH. | - |
| Kaye Spratt | M | - | - | |
| Massimiliano Colao | M | 59 | 3 Jahre | |
| Astrid Paneda Rodriguez | M | - | - | |
| Kristina Maximenko | F | - | - | |
| Scott Schorer | M | 55 | 1 Jahre | |
| Scott Nogi | M | - | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 29 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Timothy J. Miller
- Persönliches Netzwerk
